Clinical Trial Update: Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety, tolerability, and early efficacy signals of KM1 in adults with recurrent or refractory ovarian cancer. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• KM1

Snippet

Sponsor: Tongji Hospital | Conditions: Ovarian Cancer | Phase 1 | Status: RECRUITING